R
Rachel Barron
Researcher at GW Pharmaceuticals
Publications - 5
Citations - 504
Rachel Barron is an academic researcher from GW Pharmaceuticals. The author has contributed to research in topics: Randomized controlled trial & Placebo. The author has an hindex of 3, co-authored 5 publications receiving 344 citations.
Papers
More filters
Journal ArticleDOI
Cannabidiol (CBD) as an Adjunctive Therapy in Schizophrenia: A Multicenter Randomized Controlled Trial.
Philip McGuire,Philip Robson,Wiesław Jerzy Cubała,Daniel Vasile,Paul D. Morrison,Rachel Barron,Adam Taylor,Stephen Wright +7 more
TL;DR: Findings suggest that CBD has beneficial effects in patients with schizophrenia, and this agent may represent a new class of treatment for the disorder.
Journal ArticleDOI
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Pilot Study of Cannabidiol-rich Botanical Extract in the Symptomatic Treatment of Ulcerative Colitis.
Peter M. Irving,Tariq Iqbal,Chuka U. Nwokolo,Sreedhar Subramanian,Stuart Bloom,Neeraj Prasad,Ailsa Hart,Charles Murray,James O. Lindsay,Adam Taylor,Rachel Barron,Stephen Wright +11 more
TL;DR: Although the primary endpoint was not reached, several signals suggest CBD-rich botanical extract may be beneficial for symptomatic treatment of UC.
Journal ArticleDOI
17.1 a randomized controlled trial of cannabidiol in schizophrenia
Philip McGuire,Philip Robson,Wiesław Jerzy Cubała,Daniel Vasile,Paul D. Morrison,Rachel Barron,Adam Taylor,Stephen Wright +7 more
TL;DR: It is suggested that CBD has beneficial effects in patients with schizophrenia and is not associated with significant adverse effects.
Journal ArticleDOI
PTH-056 Trial to assess cannabidiol in the symptomatic treatment of ulcerative colitis
Peter M. Irving,Tariq Iqbal,Chuka U. Nwokolo,S Subramanian,Stuart Bloom,N Prasad,Alister Hart,Charles Murray,James O. Lindsay,Adam Taylor,Rachel Barron,Stephen Wright +11 more
TL;DR: Several signals suggest CBD BDS may be beneficial for symptomatic treatment of UC; larger trials are warranted.
Journal ArticleDOI
Sa1264 A Randomised, Double-Blind, Placebo-Controlled, Parallel Group, Multi-Centred Pilot Study to Assess the Symptomatic Treatment of Ulcerative Colitis With Cannabidiol
Peter M. Irving,Tariq Iqbal,Chuka U. Nwokolo,Sreedhar Subramanian,Stuart Bloom,Neeraj Prasad,Ailsa Hart,Charles Murray,James O. Lindsay,Adam Taylor,Rachel Barron,Stephen Wright +11 more
TL;DR: There was no significant benefit to seton placement prior to starting anti- TNF therapy in terms of perianal fistula healing in CD and their routine use with an anti-TNF to facilitate Fistula healing if large abscesses are absent was not supported by this study.